A carregar...
EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?
Broncho-pulmonary neuroendocrine neoplasms (BP-NENs) are neoplasms orphan of an efficient therapy. Available medical treatments derived from clinical trials are not specific for the management of this malignancy. Sunitinib is a multi-receptor tyrosine-kinases (RTKs) inhibitor that has already shown...
Na minha lista:
| Publicado no: | Endocr Connect |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bioscientifica Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6528406/ https://ncbi.nlm.nih.gov/pubmed/31035254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-19-0192 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|